nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Antithrombotic effects of aspirin based on PLA1/A2 glycoprotein IIIa polymorphism in patients with coronary artery disease
|
Dropinski, Jerzy |
|
2007 |
119 |
3 |
p. 301-303 3 p. |
artikel |
2 |
Changes in blood coagulation of arm and leg veins during a simulated long-haul flight
|
Schobersberger, Wolfgang |
|
2007 |
119 |
3 |
p. 293-300 8 p. |
artikel |
3 |
Characterization of functional P2X1 receptors in mouse megakaryocytes
|
Ikeda, Masahiro |
|
2007 |
119 |
3 |
p. 343-353 11 p. |
artikel |
4 |
Cinnamaldehyde reduction of platelet aggregation and thrombosis in rodents
|
Huang, Jingqun |
|
2007 |
119 |
3 |
p. 337-342 6 p. |
artikel |
5 |
Editorial Board
|
|
|
2007 |
119 |
3 |
p. CO2- 1 p. |
artikel |
6 |
Effect of sodium selenite supplementation on the levels of Prostacyclin I2 and Thromboxane A2 in human
|
Abdulah, Rizky |
|
2007 |
119 |
3 |
p. 305-310 6 p. |
artikel |
7 |
Factor XIII in severe sepsis and septic shock
|
Zeerleder, Sacha |
|
2007 |
119 |
3 |
p. 311-318 8 p. |
artikel |
8 |
Genetic polymorphisms of the platelet receptors P2Y12, P2Y1 and GP IIIa and response to aspirin and clopidogrel
|
Lev, Eli I. |
|
2007 |
119 |
3 |
p. 355-360 6 p. |
artikel |
9 |
Highly potent anti-human GPVI monoclonal antibodies derived from GPVI knockout mouse immunization
|
Matsumoto, Yutaka |
|
2007 |
119 |
3 |
p. 319-329 11 p. |
artikel |
10 |
Interpretation of normal plasma mixing studies in the laboratory diagnosis of lupus anticoagulants
|
Devreese, Katrien M.J. |
|
2007 |
119 |
3 |
p. 369-376 8 p. |
artikel |
11 |
Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction
|
Speidl, Walter Stefan |
|
2007 |
119 |
3 |
p. 331-336 6 p. |
artikel |
12 |
Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12® rapid analyzer: The VERIfy Thrombosis risk ASsessment (VERITAS) study
|
Malinin, Alex |
|
2007 |
119 |
3 |
p. 277-284 8 p. |
artikel |
13 |
Once atrial fibrillation, always oral anticoagulation?
|
Verheugt, Freek W.A. |
|
2007 |
119 |
3 |
p. 275-276 2 p. |
artikel |
14 |
Self-monitoring versus standard monitoring of oral anticoagulation
|
Ferretti, Gianluigi |
|
2007 |
119 |
3 |
p. 389-390 2 p. |
artikel |
15 |
The relationship between the structure of dermatan sulfate derivatives and their antithrombotic activities
|
Du, Hai-Yan |
|
2007 |
119 |
3 |
p. 377-384 8 p. |
artikel |
16 |
The respective and combined anticoagulant effects of recombinant human activated protein C, melagatran and heparins using CAT
|
Cimenti, Christina |
|
2007 |
119 |
3 |
p. 361-367 7 p. |
artikel |
17 |
Treatment of a woman with lupus and thromboembolism and cutaneous intolerance to heparins using fondaparinux during pregnancy
|
Harenberg, Job |
|
2007 |
119 |
3 |
p. 385-388 4 p. |
artikel |
18 |
What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
|
Kamphuisen, Pieter W. |
|
2007 |
119 |
3 |
p. 265-274 10 p. |
artikel |
19 |
Whole blood aggregometry for evaluation of the antiplatelet effects of clopidogrel
|
Hochholzer, Willibald |
|
2007 |
119 |
3 |
p. 285-291 7 p. |
artikel |